Joseph Fraietta, PhD, is an Assistant Professor of Microbiology at the University of Pennsylvania and directs the Solid Tumor Immunotherapy Laboratory at the Novartis-Penn Center for Advanced Cellular Therapies. As a post-doctoral fellow in Dr. Carl June’s lab, Dr. Fraietta developed new therapies through genetic modification of T cells that contributed to the initiation of multiple clinical trials and FDA approval of the first CAR T cell therapy.